Mahatme Sandesh
SEC CIK 1511034 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VOR | Vor Biopharma Inc. | CFO | 0 | — | — | 2 | 2025-07-09 | 2025-12-05 |
Most active insiders at VOR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | — | $55.62M |
| 2 | Reprogrammed Interchange LLC | 10% | — | $15.80M |
| 3 | Shah Rajeev M. | Dir, 10% | — | $13.71M |
| 4 | Kolchinsky Peter | Dir, 10% | — | $10.37M |
| 5 | RA Capital Nexus Fund, L.P. | Dir | — | $3.43M |
| 6 | Mahatme Sandesh | CFO | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-09 | 2025-12-05 | VOR | Vor Biopharma Inc. | Mahatme Sandesh | CFO | D - Sale to Iss | $0.00 | -694.1K | 0 | -100% | $0 |
| 2025-07-10 | 2025-07-09 | VOR | Vor Biopharma Inc. | Mahatme Sandesh | CFO | A - Grant | $0.00 | +13.88M | 13.88M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations